Paper7948311
Clinical and toxicological aspects of the antineoplastic drug cladribine: a review.
Guchelaar HJ and 2 others. Ann Hematol, 1994. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Clinical and toxicological aspects of the antineoplastic drug cladribine: a review. Papers, record 7948311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7948311
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cladribine | Major topic |
| Adenosine Deaminase | |
| Humans | |
| Lymphocytes |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1346577 | Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). | Blood | 1992 | https://conductscience.org/library/papers/1346577 | PubMed |
| 2 | 6256765 | Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6256765 | PubMed |
| 3 | 8104670 | 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia. | Cancer Invest | 1993 | https://conductscience.org/library/papers/8104670 | PubMed |
| 4 | 1969613 | Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. | N Engl J Med | 1990 | https://conductscience.org/library/papers/1969613 | PubMed |
| 5 | 1355673 | 2-Chlorodeoxyadenosine in the treatment of multiple myeloma. | Blood | 1992 | https://conductscience.org/library/papers/1355673 | PubMed |
| 6 | 1361080 | New antimetabolites in the treatment of human malignancies. | Semin Oncol | 1992 | https://conductscience.org/library/papers/1361080 | PubMed |
| 7 | 6585795 | Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6585795 | PubMed |
| 8 | 1346800 | 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1346800 | PubMed |
| 9 | 8093300 | Complete remission of B-cell chronic lymphocytic leukaemia after oral cladribine. | Lancet | 1993 | https://conductscience.org/library/papers/8093300 | PubMed |
| 10 | 1357107 | On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1357107 | PubMed |
| 11 | 27463495 | 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia. | Leuk Lymphoma | 1991 | https://conductscience.org/library/papers/27463495 | PubMed |
| 12 | 27463204 | 2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside. | Leuk Lymphoma | 1991 | https://conductscience.org/library/papers/27463204 | PubMed |
| 13 | 1346575 | 2-Chlorodeoxyadenosine treatment of lymphoid malignancies. | Blood | 1992 | https://conductscience.org/library/papers/1346575 | PubMed |
| 14 | 1357106 | 2-Chlorodeoxyadenosine: drug development priorities. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1357106 | PubMed |
| 15 | 8094003 | 2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8094003 | PubMed |
| 16 | 8097653 | Nucleoside analogs in treatment of chronic lymphocytic leukemia. | Leuk Lymphoma | 1993 | https://conductscience.org/library/papers/8097653 | PubMed |
| 17 | 8427892 | Chronic lymphoproliferative disorders: chronic lymphocytic leukemia and hairy-cell leukemia. | Curr Opin Oncol | 1993 | https://conductscience.org/library/papers/8427892 | PubMed |
| 18 | 1349035 | The purine analogs--a therapeutic beauty contest. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1349035 | PubMed |
| 19 | 7691237 | Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. | Blood | 1993 | https://conductscience.org/library/papers/7691237 | PubMed |
| 20 | 8094888 | 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8094888 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41240270 | Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system. | Int J Clin Pharm | 2026 | https://conductscience.org/library/papers/41240270 | PubMed |
| 23390564 | Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells. | Am J Transl Res | 2013 | https://conductscience.org/library/papers/23390564 | PubMed |
| 20127230 | [Cladribin. Development of an oral formulation for the treatment of multiple sclerosis]. | Nervenarzt | 2010 | https://conductscience.org/library/papers/20127230 | PubMed |
| 19921304 | Development of oral cladribine for the treatment of multiple sclerosis. | J Neurol | 2010 | https://conductscience.org/library/papers/19921304 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADA | 100 | PubTator's text mining | https://conductscience.org/library/genes/100 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7948311
GET https://conductscience.org/api/papers/v1/7948311/references?page=2